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Vagus nerve stimulation (VNS) therapy is associated with laryngeal muscle activation
and induces voice modifications, well-known side effects of the therapy resulting from
co-activation of the recurrent laryngeal nerve. In this study, we describe the non-invasive
transcutaneous recording of laryngeal motor evoked potentials (LMEPs), which could
serve as a biomarker of effective nerve activation and individual titration in patients
with drug-resistant epilepsy. We recruited drug-resistant epileptic patients treated for
at least 6 months with a VNS. Trains of 600–1200 VNS pulses were delivered with
increasing current outputs. We placed six skin electrodes on the ventral surface of
the neck, in order to record LMEPs whenever the laryngeal muscular threshold was
reached. We studied the internal consistency and the variability of LMEP recordings,
and compared different methods for amplitude calculation. Recruitment curves were
built based on the stimulus–response relationship. We also determined the electrical
axis of the LMEPs dipole in order to define the optimal electrode placement for
LMEPs recording in a clinical setting. LMEPs were successfully recorded in 11/11
patients. The LMEPs threshold ranged from 0.25 to 1 mA (median 0.50 mA), and onset
latency was between 5.37 and 8.77 ms. The signal-to-noise ratio was outstanding
in 10/11 patients. In these cases, excellent reliability (Intraclass correlation coefficient,
ICC > 0.90 across three different amplitude measurements) was achieved with 10
sample averages. Moreover, our recordings showed very good internal consistency
(Cronbach’s alpha > 0.95 for 10 epochs). Area-under-the-curve and peak-to-peak
measurement proved to be complementary methods for amplitude calculation. Finally,
we determined that an optimal derivation requires only two recording electrodes, aligned
on a horizontal axis around the laryngeal prominence. In conclusion, we describe here an
optimal methodology for the recording of VNS-induced motor evoked responses from
the larynx. Although further clinical validation is still necessary, LMEPs might be useful
as a non-invasive marker of effective nerve activation, and as an aid for the clinician to
perform a more rational titration of VNS parameters.
Keywords: vagus nerve stimulation (VNS), epilepsy, biomarkers, larynx, motor evoked potentials, internal
consistency, reliability, electrical axis
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INTRODUCTION
Epilepsy is considered ‘drug-resistant’ when the patient is not
seizure free despite treatment with at least two anti-epileptic
drugs at correct dosages (Kwan et al., 2010). In such cases,
patients are referred to a specialized epilepsy center for pre-
surgical evaluation. When surgery is not indicated, for example
in the case of generalized epilepsy, or of a non-localizable
or multifocal seizure onset, neuromodulation by vagus nerve
stimulation (VNS) may be an effective alternative. VNS was
developed in the ‘80s and consists of an implanted device
that generates and delivers electrical pulses to the left cervical
vagus nerve by means of helical electrodes. The efficacy of
VNS has been confirmed by randomized controlled trials (Ben-
Menachem et al., 1994; Handforth et al., 1998) and meta-
analysis (Englot et al., 2011). Despite the demonstrated clinical
efficacy, one third of patients still do not benefit from the
therapy and are classified as ‘non-responders’ (Boon et al., 2002).
The response to VNS is variable from patient to patient, both
in terms of efficacy and of side effects (Vonck et al., 2004).
The mechanisms of action of VNS remain poorly understood
(Krahl and Clark, 2012) and there is a lack of established
predictors of efficacy applicable to individual subjects (Ghaemi
et al., 2010; Englot et al., 2016). One of the possibilities to
improve the therapy would be to characterize a biomarker for
effective vagal nerve fiber activation, which is a prerequisite
for therapeutic efficacy. An objective biomarker could aid
neurologists to titrate the delivered electrical current (defined by
the stimulation parameters) in a more rational and personalized
manner. Such an attempt was made by recording cortical
potentials evoked intraoperatively by the VNS (Usami et al.,
2013). These authors used muscle relaxants to demonstrate that
the early components of their responses were linked to afferent
vagal signals, whereas late components were related to VNS-
induced motor activity.
In the hope to develop a non-invasive alternative that would
be more applicable in clinical routine, we explored the muscular
effects of the vagal stimulation. VNS therapy co-activates the
recurrent laryngeal nerve, which branches off from the vagus
nerve at the level of the aortic arch, below the standard location
of the implanted electrode. The recurrent laryngeal nerve carries
low threshold vagal Aα motor fibers innervating all the laryngeal
muscles (except the cricothyroid) and part of the pharynx (Krahl,
2012). Among the side effects reported by patients implanted
with VNS, voice alteration during stimulation periods affects
20 to 62% of them (DeGiorgio et al., 2000; Zalvan et al., 2003;
Englot et al., 2011). These symptoms are explained by an irregular
contraction of antagonist intrinsic laryngeal muscles (Kersing
et al., 2002). VNS-induced activation of the recurrent laryngeal
nerve results in laryngeal motor evoked potentials (LMEPs),
which were previously successfully recorded intraoperatively in
animals with implanted cervical vagus nerve electrodes (El Tahry
et al., 2011; Mollet et al., 2013; Grimonprez et al., 2015). Nerve
lesions and blocking of neuromuscular junction at laryngeal level
confirmed the motor origin of the recorded responses. Animal
evidence on LMEPs was later translated into a clinical setting, and
LMEPs were specifically recorded in epileptic patients through
surface cervical electrodes, in different orientations around the
larynx (Bouckaert et al., 2018).
The present study is a feasibility study with the aim of
confirming the possibility of non-invasive recording of LMEPs
in patients treated with VNS therapy. The primary goal of this
study is to establish the optimal clinical routine methodology
for surface recording of human VNS-induced LMEPs, and to
extract their most pertinent features. We describe the general
characteristics of LMEP recordings, including onset latency,
amplitude, and variability as well as individual recruitment
(stimulus–response) curves. In addition, we explored the optimal
bipolar electrode orientation and sought the most reliable LMEP
amplitude quantification method.
MATERIALS AND METHODS
Patient Selection
Drug-resistant epileptic patients treated with VNS therapy
were recruited from the VNS follow-up database of the Centre
for Refractory Epilepsy of Saint Luc University Hospital,
Brussels, Belgium. The Ethics Committee of Saint-Luc
Hospital approved the study procedures (Reference No.
2018/07NOV/416). Informed consent to the study was given
prior to any investigation. Inclusion criteria were: (i) patient
aged between 18 and 65 years; (ii) implanted cervical VNS device
(DemiPulse
R©
Model 103 or DemiPulse Duo
R©
Model 104 or
AspireHC
R©
Model 105 or AspireSR
R©
Model 106; LivaNova,
Inc., London, United Kingdom) for at least 6 months; (iii) VNS
electrode impedance between 2 and 5 kOhm, as assessed on the
day of the investigation. Exclusion criteria were: (i) presence
of a concomitant laryngeal pathology or recurrent laryngeal
nerve damage, independent from VNS; (ii) important VNS side
effects reported by the patient, such as severe dyspnea (grade
III–IV) or severe pain in the neck/ear region. Intermittent
hoarseness was allowed. The clinical response to VNS was
determined based on the clinical report of the latest available
follow-up visit. Patients were considered as responders to VNS
if a reduction ≥ 50% in seizure frequency was obtained. If
the reduction in seizure frequency was < 50%, patients were
considered as non-responders.
Techniques
The experiments were performed at the Neurophysiology
Unit of Saint Luc University Hospital, Brussels, Belgium.
Evoked potentials (EP) were recorded using an EEG/EP digital
acquisition system (Matrix 1005, Micromed, Mogliano Veneto,
Italy). Sampling rate was set at 32 kHz (except for one case
sampled at 2048 Hz), with a voltage window of ± 200 µV.
High-pass filtering was 0.15 Hz (time constant = 1 s). Low-
pass cut-off was 8 kHz for cases sampled at 32 kHz, and
540 Hz for the case sampled at 2048 Hz. The impedance of
the VNS lead electrode was checked by means of the standard
handheld programing wand before starting the procedure. If an
impedance > 5 kOhm was measured, the patient was excluded
from the study. Seven surface electrodes (Skintact FS-50 Gel
ECG Electrodes) were placed on the skin of the patient after
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local skin scrubbing with Weaver Prep Gel. On the ventral
skin surface of the patient’s neck, four electrodes were arranged
in two bipolar derivations: one vertical (EV−/EV+) and one
horizontal (EH−/EH+). The EV−/EV+ electrodes were placed
6 cm above and below the laryngeal prominence, respectively;
EH−/EH+ were placed symmetrically and horizontally to the
right and to the left of the same reference point, at half the
distance between the laryngeal prominence and the medial edge
of the sternocleidomastoid muscle, i.e., about 4 cm laterally to
the midline (see Figure 1). Two additional electrodes (Art1/Art2)
were placed laterally on the left mastoid and below the middle
part of the left clavicle respectively, forming a recording channel
FIGURE 1 | (A) Schematic representation of the recording surface electrode placement. EH+/EH– electrodes were aligned horizontally, and placed symmetrically on
each side of the laryngeal prominence, at half the distance between the midline and the medial edge of the sternocleidomastoid muscle (approximately 4 cm).
EV+/EV– electrodes were aligned vertically, placed on the midline 6 cm above and below the laryngeal prominence. Additionally, two electrodes for artifact recording
(Art1–Art2) were placed on the left mastoid and below the left clavicle side of the neck (not shown in figure), and one grounding electrode was placed on the
forehead (not shown in figure). The distances take into account an approximation due to the curvature of the neck and due to the perspective of the image.
(B) Scheme of the stimulation protocol.
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in-line with the stimulation artifact. Grounding was insured by
a forehead electrode. After connection to the acquisition system,
skin electrode impedances were checked to be < 20 kOhm.
Stimulation Protocol
At onset, patients were asked to minimize neck movements
and to refrain from speaking. Therapeutic VNS (‘Normal
stimulation’) was temporarily switched off by setting the current
output to 0 mA. A 2-min baseline recording was acquired before
LMEP elicitation in order to allow high pass filter stabilization.
VNS was activated on-demand by sweeping an external magnet
over the implanted stimulator, while the recording was running.
The starting current output was set at 0.25 mA, and then was
gradually ramped up by steps of 0.25 mA at each magnet sweep.
Based on the individual patient’s therapeutic current output
(Xstim), we stimulated until a value of Xstim + 0.25 mA was
reached (see Figure 1). In order to ensure similar conditions
across patients, pulse width and frequency were left unchanged
at respectively 250 µs and 20 Hz. Each magnet sweep was
programed to produce a 30 or 60 s train of stimulation (VNS On
time according to the patient’s tolerability) each yielding 600 or
1200 VNS pulses per current output level.
Data Analysis
Signals were analyzed offline using MATLAB 2018a software
(MathWorks, Natick, MA, United States). Automatic trigger
detection was performed on MATLAB, with the zero reference
time corresponding to the first negative flank of the VNS
stimulation artifact at electrode EH−. A 50 Hz notch filter
was applied to the electromyographic recording, which was
thereafter segmented in samples from −3 to + 25 ms around
the corresponding stimulation artifact. Hereafter, we thus refer
to these individual 28 ms samples as ‘epochs.’ The pre-processing
ended with a baseline correction. All epochs obtained at the same
current output were overlaid and visually screened for outliers,
e.g., epochs from segments affected by major artifacts (mostly
coughing, phonation, or other patient movement). Due to a
“ramp-up” and “ramp-down” of the current output during the
first and last 2 s of stimulation trains, epochs not corresponding
to the pulses at target current intensity were also excluded.
Laryngeal motor evoked potentials were defined as the
reproducible bi- or tri-phasic waveforms appearing as an all-
or-nothing response to the stimulation, with an expected onset
latency range of 5–9 ms, as described in previous invasive
laryngeal EMG studies (Ardesch et al., 2010). For each patient,
we first determined the threshold, i.e., the lowest current output
(a multiple of 0.25 mA) sufficient to evoke LMEPs visible either
in single traces or after averaging. We determined the following
LMEP characteristics (Figure 2):
- Latency: the time between the negative peak of the stimulation
artifact and the initial negative (at EH−) deflection of LMEP
(t0–p1).
- Duration: the time between the first LMEP negative deflection
(p1) and the return to baseline (p2).
- Peak-to-peak (P2P) amplitude: the peak-to-peak difference
between the initial N1 peak and the following P1 peak.
- Area-under-the-curve (AUC) amplitude: the integral of N1 and
P1 waves, all referred to the p1-p2 line as zero level.
- Prominence amplitude (N1 prominence): the amplitude of N1
peak over the p1 amplitude value, taken as zero level.
Amplitude Measurements
Different methods can be applied to quantify the amplitude of a
motor EP, based on either peak sizes or signal integration (area)
measurements. Different metrics are widely accepted (Lavoie
et al., 1995; Cacchio et al., 2009; Joyeux et al., 2017). We compared
the results of the LMEP amplitude evaluation using a P2P
metric, a single peak amplitude (N1 prominence) and the integral
AUC measurements.
For each measure, we calculated the mean values per train
of stimulation based on the grand average (average over the
maximum number of epochs available in a train). We first
measured the mutual agreement of the three different amplitude
measurements, as an indication of their inter-exchangeability
and of the overall reliability of EP measures (Joyeux et al.,
2017). We calculated the ICC(3,k) for inter-rater reliability,
in which each method is considered as a different rater, and
their consistency across trials is tested (McGraw and Wong,
1996; Koo and Li, 2016; Joyeux et al., 2017). Values of
ICC > 0.75 are considered as an indicator of good reliability,
and values > 0.90 of excellent reliability (Koo and Li, 2016).
In addition, we measured the variability within one train
of stimulation for each method and calculated their relative
coefficient of variation (CV) = %(SD/mean values) per train.
CV can provide information on whether the measurement
is more or less sensitive to intra-train fluctuations, such as
respiration, but also provides an indirect estimate of the signal-
to-noise ratio (SNR) – the lower the CV, the higher the SNR
(Okamoto et al., 2015).
Internal Consistency Analysis: Cronbach’s Alpha and
Pearson’s Correlation Coefficient
Based on the recording hardware, on the nature of the
quantification method and on the SNR, EP single epoch
recordings may have lower or higher internal consistency
across observations (Fabiani et al., 1987; Thigpen et al., 2017).
The estimation of internal consistency is thus crucial in
defining how many epochs should be averaged for the EP
characteristics measurements to yield reliable results (Cohen
and Polich, 1997; Olvet and Hajcak, 2009; Goldsworthy et al.,
2016). Internal consistency can be practically evaluated using
Cronbach’s alpha, which characterizes the similarity between
repeated measurements by correlating all possible subsets of
the measurements (Cronbach and Warrington, 1951; Fabiani
et al., 1987; Thigpen et al., 2017). Values > 0.9 indicate excellent
internal consistency (Hinton et al., 2014).
In the present study, we investigated the internal consistency
of LMEPs, using Cronbach’s alpha and Pearson’s correlation
coefficient, with a double purpose: (i) to define a minimal number
of epochs to be included in each average in order to yield
consistent measurements; (ii) to identify the response amplitude
metrics showing the highest internal consistency (see section
“Amplitude Measurements”). We analyzed the values of LMEP
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FIGURE 2 | An example of LMEP and its characteristics, as displayed in a 28 ms epoch. The different measurements for amplitude that were are studied are
indicated: area-under-the-curve (AUC), peak-to-peak (P2P), and N1 prominence.
amplitude across increasing numbers of epochs (5, 10, 20, 50,
100, 200) selected randomly from a same train. First, matrices
for Cronbach’s alpha calculation were built with single-epoch
amplitude value in a given metric, while the different patients
accounted for different observations (Fabiani et al., 1987; Thigpen
et al., 2017). Alpha values were obtained for each number of
epochs, and for each amplitude metric.
In addition, in order to assess the effect of the number of
epochs on the final results, we compared the correlation of
small-number averages (i.e., obtained with 5, 10, 20, 50, 100,
200 epochs) with the grand average. This was quantified on the
basis of a Pearson correlation coefficient (Olvet and Hajcak, 2009;
Rietdijk et al., 2014).
Recruitment Curves
We aimed to fit a Boltzmann sigmoid function to the recruitment
curves (Devanne et al., 1997), in order to describe the LMEP
amplitudes (in µV) according to the following function of the
stimulus current (in mA):
LMEP amplitude = LMEPmax[1+ exp((I50 − I)/k)] (1)
where LMEPmax is the maximum value reached by LMEP
amplitude, I50 is the stimulus current value at which the response
amplitude reaches half LMEPmax and k is the slope of the curve.
Only curves with one current value below threshold, two at
the level of LMEPmax (indicating saturation) and two on the
ascending part of the slope, were considered for fitting with the
equation above. Goodness of fit was reported in terms of r2 values
(good fit = r2 > 0.95) and root mean square error (RMSE).
Electrical Axis
Only laryngeal muscles ipsilateral to the stimulated left vagus
nerve are expected to be activated (Kersing et al., 2002; Ardesch
et al., 2010). Therefore, despite the various orientations of
these muscles, the resulting potential vector was expected to be
asymmetrical between the left and the right side. We aimed to
determine the amplitude and direction of the maximal LMEP
electrical axis, considering the two orthogonal derivations in the
frontal plan as given by the EH and EV channels (Figure 1).
The horizontal vector to the right (EH+ electrode) is taken as
(0◦), while the value of 90◦corresponds to the upwards vertical
direction (EV+). The ALMEP (Dipole vector amplitude) and
DLMEP (Dipole vector orientation) were calculated according to
the equations:
ALMEP = SQRT(EV(tMax)2 + EH(tMax)2) (2)
DLMEP = ± arctan
(
EV(tMax)
EH(tMax)
)
(3)
where EV(tMax) and EH(tMax) are the amplitude in the vertical
and horizontal derivation respectively at the time in which the
sum of the latter two amplitudes reaches the highest value.
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Electrodes Placement
In one patient, we tested how the distance of the electrodes
from the midline could affect the qualitative and quantitative
aspects of the recordings (SNR, amplitude of signals). To do so,
we placed the electrodes laterally to the laryngeal prominence
at three different distances: 2 cm, half distance to the medial
edge of the sternocleidomastoid muscle as used in the rest of
the recordings (i.e., about 4 cm) and close to the medial edge of
the sternocleidomastoid muscle (i.e., about 6 cm) (Figure 1), and
compared the obtained results. In the patient where this test was
performed, no EV electrodes were placed.
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics for
Windows, version 2.0 (IBM, Corp., Armonk, NY, United States).
Mean values, standard deviation (SD) and 95% confidence
intervals (C.I.) are reported unless stated otherwise. One-way
ANOVA was used to assess whether significant differences existed
between CV values across the three amplitude measurements.
Statistical significance was considered at p < 0.05. More
specific analyses, such as reliability statistics, are described
above in the text.
RESULTS
Laryngeal motor evoked potentials were successfully recorded in
all 11 patients (eight females, three males; mean age: 35.7 years).
The mean time between implantation and the present testing was
67.9 months (range: 8–169 months). 3/11 patients were classified
as responders to VNS therapy, while 8/11 as non-responders.
A detailed list of patient records is provided in Table 1. In
9/11 patients, LMEPs were predominantly visible in the EH
compared to the EV channel. In 2/11 patients (PAT 8, PAT
9) LMEPs appeared with comparable amplitudes in both EH
and EV channels. The stimulation artifact was equally visible in
all three derivations (EV, EH, and Art), and appeared with an
initial negative peak in reference to EH− electrode. Hereafter, all
reported results refer to recordings from the EH channel except
for analysis of the dipole orientation.
Laryngeal motor evoked potentials were highly reproducible
at intra and inter-patient level (Figure 3 and Table 2). For each
recorded train of pulses, 210 to 1200 valid epochs (mean = 893)
were included in the grand average. Within a train, all LMEP
characteristics (amplitudes, latency, and duration) showed a
normal Gaussian distribution. LMEPs followed the stimulation
artifact with a mean onset latency of 6.89 ms (range: 5.37–
8.72 ms). The sampling rate at 2048 Hz (PAT 2) did not affect
the main features of LMEPs. The mean duration of the responses
was 10.6 ms (range: 8.03–14.65 ms).
Amplitude Measurements and Internal
Consistency
Excellent mutual agreement was found across the three different
amplitude measurement methods, with ICC = 0.943 (C.I. 0.806–
0.988) for the grand average. The ICC was already > 0.9 when
averaging 10 epochs, and it evolved only minimally when more
epochs were added (Table 3).
The amplitude measurement with the lowest CV per train
was obtained with the P2P method (mean: 10.90%, SD:
3.38%), followed by AUC (mean: 12.28%, SD: 3.99%) and N1
prominence (mean: 14.12%, SD: 4.36%). However, there was no
significant difference between the mean values (one-way ANOVA
test, p = 0.183).
Figure 4 shows the Cronbach’s alpha values calculated
with increasing numbers of epochs in 10/11 patients, where
a high SNR allowed measurement of amplitudes on single
epochs. Considering all the three amplitude measurements,
alpha values reached > 0.95 with 10 epochs averaged. Alpha
values tend to a plateau (>0.99) when more than 50 epochs
are included. Among the three methods, the AUC method
showed the highest values of alpha at all numbers of
epochs considered.
When calculating the Pearson correlation coefficient
between the amplitude measurements of the small-
number average and the grand average (Figure 4 and
TABLE 1 | Clinical records of the study population.
Duration Pulse Clinical
Age of VNS generator response VNS clinical
PAT no. (range) implant VNS normal parameters model Epilepsy type to VNS side effects
PAT 1 26–30 4y 10m 1.75 mA; 20 Hz; 250 usec; 30 s On 3 min Off 106 Focal epilepsy, unknown etiology NR NA
PAT 2 21–25 8m 1 mA; 30 Hz; 500 usec; 30 s ON 5 min Off 106 Focal epilepsy, unknown etiology R Hoarseness
PAT 3 61–65 8y 3m 1.5 mA; 20 Hz; 250 usec; 14 s On 1.1 min Off 103 Focal epilepsy, structural etiology NR NA
PAT 4 31–35 6y 2m 1.75 mA; 25 Hz; 250 usec; 30 s On 5 min Off 103 Focal epilepsy, infectious etiology NR NA
PAT 5 31–35 8y 1m 2 mA; 25 Hz; 250 usec; 30 s On 1.1 min Off 106 Focal epilepsy, genetic etiology NR NA
PAT 6 18–20 2y 2m 1.25 mA; 20 Hz; 250 usec; 30 s On 5 min off 106 Focal epilepsy, unknown etiology NR NA
PAT 7 26–30 4y 1 mA; 20 Hz; 250 usec; 30 s On 5 min Off 103 Generalized epilepsy, R NA
PAT 8 51–55 14y 1m 1 mA; 30 Hz; 500 usec; 30 s On 5 min Off 103 Focal epilepsy, structural etiology NR NA
PAT 9 51–55 5y 8m 1 mA; 30 Hz; 500 usec; 30 s On 5 min Off 106 Focal epilepsy, structural etiology R Transient neck pain
PAT 10 18–20 4y 5m 1.75 mA; 30 Hz; 500 usec; 30 s On 5 min Off 103 Focal epilepsy, unknown etiology NR NA
PAT 11 41–45 3y 11m 1.75 mA; 20 Hz; 500 usec; 30 s On 5 min Off 103 Focal epilepsy, unknown etiology NR Hoarseness
R, responder (≥50% seizure frequency reduction). NR, non-responder (<50% seizure frequency reduction).
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FIGURE 3 | Example of LMEP single epochs, in patients with a good signal-to-noise ratio (SNR) and sampling rate at 32 kHz. (A) Intra-patient reproducibility (PAT 1),
in different trains at increasing current output. (B) LMEPs recorded across different patients, at their respective normal current output (1–1.75 mA). Variation of
amplitudes and latencies can be appreciated. Latencies are comprised in a 5.4–8.7 ms range (mean: 6.89 ms). PAT 2 is not shown due to a sampling rate of
2048 Hz that hampers a meaningful overlay. PAT 5 is not shown due to low SNR.
TABLE 2 | Laryngeal motor evoked potential (LMEP) characteristics at therapeutic current output (Xstim) and calculated based on the grand average.
Threshold Latency Duration
PAT no. (mA) (ms) (ms) P2P amplitude (µV) AUC amplitude (µV x ms) N1 prominence amplitude (µV)
PAT 1 0.75 6.26 10.29 Mean = 204.8 ± 19.03 Mean = 17346 ± 1562.5 Mean = 157.74 ± 17.26
PAT 2 0.5 5.37 14.65 Mean = 178.15 ± 14.86 Mean = 11918 ± 101 Mean = 65.46 ± 14.56
PAT 3 0.75 7.11 9.24 Mean = 172.67 ± 24.32 Mean = 11703 ± 2049.5 Mean = 96.12 ± 14.09
PAT 4 0.25 6.41 12.05 Mean = 181.55 ± 16.29 Mean = 15570.7 ± 1323 Mean = 141.02 ± 10.53
PAT 5 1 8.33 11.26 Mean = 75.26 ± NA Mean = 8180.3 ± NA Mean = 66.69 ± NA
PAT 6 0.5 5.4 11.08 Mean = 238.35 ± 11.64 Mean 23300.3 ± 1044.6 Mean = 175.31 ± 13.6
PAT 7 0.5 6.93 8.15 Mean = 138.21 ± 15.83 Mean = 14164.7 ± 1834 Mean = 112.75 ± 14.91
PAT 8 0.75 6.81 8.03 Mean = 66.83 ± 10.94 Mean = 6612 ± 1063.7 Mean 52.37 ± 9.3
PAT 9 0.25 8.08 11.17 Mean = 169.92 ± 11.91 Mean = 14422.7 ± 1258.9 Mean = 136.05 ± 10.8
PAT 10 0.25 6.35 10.44 Mean = 205.74 ± 16.4 Mean = 19204.8 ± 17.63 Mean = 179.72 ± 15.91
PAT 11 0.5 8.72 10.22 Mean = 180.98 ± 5.33 Mean = 12923.5 ± 17.78 Mean = 140.74 ± 6.18
PAT 5 measures were based on averaged parameters, therefore no SD was available.
TABLE 3 | Values of inter-rater reliability (ICC) of the three methods (P2P, AUC, and N1 prominence) and internal reliability (Cronbach’s alpha and Pearson’s correlation
coefficient between averages), calculated in patients with good signal-to-noise ratio (n = 10) at their normal current output.
5 epochs 10 epochs 20 epochs 50 epochs 100 epochs 200 epochs
ICC 0.88 (0.60–0.97) 0.90 (0.67–0.98) 0.91 (0.70–0.98) 0.92 (0.74–0.98) 0.92 (0.73–0.98) 0.91 (0.70–0.98)
Peak-to-peak (P2P) Alpha 0.907 0.962 0.984 0.993 0.996 0.998
Pearson 0.926 0.955 0.954 0.960 0.975 0.974
Area-under-the-curve (AUC) Alpha 0.979 0.990 0.994 0.997 0.999 0.999
Pearson 0.988 0.991 0.989 0.991 0.993 0.996
N1 prominence (N1) Alpha 0.959 0.978 0.991 0.996 0.998 0.999
Pearson 0.968 0.981 0.981 0.986 0.996 0.996
Table 3), AUC method showed the best correlation (>0.99
with 10 epoch average included). All three amplitude
measurements yielded an excellent internal consistency
from 10-epochs average on (Pearson’s coefficient > 0.95
for AUC, P2P, and N1 prominence). No substantial
benefit was obtained if more than 100 epochs were
included in the average.
Due to a low SNR, averaging was necessary to identify
the LMEP in one single patient (PAT 5). In this case, only
measurement values obtained from averaged epochs were
Frontiers in Neuroscience | www.frontiersin.org 7 August 2019 | Volume 13 | Article 880
fnins-13-00880 August 24, 2019 Time: 16:23 # 8
Vespa et al. VNS-Induced Laryngeal MEPs
FIGURE 4 | Internal consistency of LMEPs, in the case of good SNR. (A) LMEP recordings recorded from PAT 4. At the top of the figure, overlay of maximal amount
of 1200 LMEPs. In the middle, overlay of randomly chosen 20 LMEPs. At the bottom, overlay of the averages from 1200 (blue line) and 20 curves (orange line),
showing excellent robustness (Pearson’s coefficient > 0.95). (B) Values of Cronbach’s alpha for the peak-to-peak (P2P), area-under-the-curve (AUC) and N1
prominence amplitude calculation, at increasing number of curves included in the trial count. (C) Pearson’s correlation coefficient between LMEP amplitude results
for small-number averages with those obtained at grand average.
available, thus precluding the calculation of a Cronbach’s alpha
value. However, a slightly different method is available to
assess the internal consistency of LMEP amplitude results,
as a surrogate for the Cronbach’s alpha calculation (Green
et al., 2016). We compared the amplitude values (P2P,
AUC, N1 prominence considered altogether) from consecutive
odd-numbered epochs with those from consecutive even-
numbered epochs, for 10, 20, 50, 100, 200 and maximal
number of epochs at 3 different current outputs (1, 1.5,
2 mA). As shown in Figure 5, averaged traces became
stackable and the amplitudes consistent from 100 averaged
epochs onwards (Pearson correlation coefficient > 0.90),
while higher numbers did not significantly improve the
traces Table 4.
Recruitment Curves
Laryngeal motor evoked potentials grand average P2P amplitude
was plotted – with linear interpolation for the sake of
clarity, as a function of the stimulation current for all
11 patients, and is shown in Figure 6. In only 3/11
cases there were enough data points available to fit a
Boltzmann equation (values of R2 > 0.95). The calculated
values of I50 were 0.50 mA (PAT 2), 0.86 mA (PAT 3),
and 0.55 mA (PAT 9); values of k were 0.145, 0.148, and
0.082 µV/mA, respectively.
Electrical Axis
In 10 patients, LMEPs were recorded in both EH and EV
channels and the LMEP dipole vector could be calculated
(Figure 7). DLMEP had a mean value of 0.51◦ (range, minimum
−72.84◦ maximum 44.17). In all measurements dipoles were
directed to the right side, if considering the horizontal plane
(toward EH+) Table 5.
Electrode Placement
Figure 8 shows three trains of 600 pulses delivered at
the same current output of 1.75 mA in one patient
(PAT 11), recorded with EH electrodes placed at different
distances in the horizontal plane. In Table 6, the mean P2P
values, and CV are summarized. P2P values and CV are
comparable across the three placements with no statistically
significant difference. However, visual analysis of LMEP
single epochs shows that high-frequency muscular artifacts
particularly affect the recording with EH electrodes at 6 cm of
distance (Figure 8).
DISCUSSION
This study shows that VNS-induced laryngeal muscular
activation can be reliably recorded in a non-invasive manner,
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FIGURE 5 | Laryngeal motor evoked potentials (LMEPs) recorded from PAT 5, which was the only patient with low signal-to-noise ratio. Comparison of average
parameters at increasing number of epochs (10, 20, 50, 100, 200, maximum). (A) Consecutive odd-numbered single epochs were overlaid and averaged (blue color)
and compared to consecutive even-numbered epochs (orange color). (B) Averaged curves were compared between them, with an increasing consistency of the
curves across the two subgroups. Amplitude measurements become highly consistent as the number of epochs included in the average reaches 100 curves
(Pearson correlation > 0.90).
TABLE 4 | Odd-even reliability of small-number averages in PAT 5 (low signal-to-noise ratio) were calculated by Pearson’s correlation coefficient.
10 epochs 20 epochs 50 epochs 100 epochs 200 epochs Grand
Odd-even reliability 0.537 0.603 0.701 0.945 0.944 0.923
The calculation was made taking into account the three different methods of amplitude calculation (peak-to-peak, area-under-the-curve, N1 prominence).
in patients chronically implanted with VNS. We successfully
recorded LMEPs transcutaneously in 11 patients treated with
VNS, at different time points during their therapy (from
8 months up to 14 years). The presence of LMEPs after many
years of treatment with VNS therapy (>10 years) encourages
their application in the chronic follow-up of the integrity of the
lead-nerve interface. As valuable additional information to the
electrode impedance test, measuring LMEPs can guarantee to the
clinician an efficient activation of the nerve fibers.
The recorded LMEPs consisted of a N1 and P1 peak, with
N1 earliest deflection appearing at 6.89 ms (range: 5.37–8.72 ms)
after the first peak of the stimulation artifact. This finding is
highly concordant with previous invasive assessments of VNS-
induced laryngeal muscular responses reported by Ardesch et al.
(2007), where a mean latency of 6.7 ms (range: 5.25–9.75 ms)
was reported in eight patients. Thresholds for laryngeal muscle
activation ranged between 0.25 and 1 mA, for a pulse width of
250 µs. With invasive recording and using the same stimulus,
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FIGURE 6 | Recruitment curve of LMEP amplitude (peak-to-peak values)
visualized by linear interpolation.
FIGURE 7 | Electrical axis of LMEP dipole (DLMEP). A vector directed toward
0◦ means a horizontal vector directed to the right. A vector directed toward
90◦ means a vertical vector directed cranially. Single-patient (gray) and mean
values (red) are displayed.
Ardesch et al. (2007) found a left vocal fold EMG-threshold
between 0.25 and 0.50 mA, and saturation levels between 0.75 and
1.00 mA, which are comparable to our results.
The dipole orientation of the muscular response is mainly
horizontal, directed to the right with a slight and variable
inclination either cranially or caudally. The optimal placement
TABLE 5 | Values of LMEP dipole electrical axis (DLMEP).
DLMEP(◦)
PAT 1 29.63
PAT 2 4.86
PAT 3 10.06
PAT 4 27.83
PAT 5 −11.36
PAT 6 40.56
PAT 7 −50.16
PAT 8 −72.84
PAT 9 44.17
PAT 10 −17.63
Mean 0.51
A 0◦ angle equals to a horizontal axis directed to the right. Positive angles express
a cranial deviation of the axis.
TABLE 6 | Results of LMEP peak-to-peak amplitude in PAT 11, as recorded with
EH electrodes placed at 2, 4, and 6 cm laterally to the laryngeal prominence.
Mean P2P (µV) SD (µV) CV
2 cm 191.58 25.73 13.43%
4 cm 171.89 22.65 13.18%
6 cm 172.21 25.65 14.89%
P2P, peak-to-peak amplitude; SD, standard deviation; CV, coefficient of variation.
of the surface recording electrodes is thus horizontal, and a
single horizontal recording dipole is sufficient. We propose to
place the electrodes symmetrically halfway between the laryngeal
prominence and the medial edge of the sternocleidomastoid
muscle. This corresponds to about 4 cm horizontally on each
side of the laryngeal prominence (EH+/EH− derivation shown
in Figure 1). As far as possible from muscular interferences,
this placement allows to be anatomically as close as possible
to the intrinsic laryngeal musculature, and inter-electrode
distance of approximately 8 cm allows recording from deeper
sources as required.
We found an excellent reliability (ICC > 0.9) of the 600 to
1200 responses within a single train, regardless of the amplitude
metrics used. The high internal consistency not only highlights
a noise level requiring little averaging but also indicates that the
measurement considered is physiologically stable. The P2P and
AUC metric are almost equally valuable, but in cases of partial
demyelination for example, the P2P value might be reduced while
the AUC remains constant. Both methods might thus have a
complementary value in some cases. Moreover, our results also
show that averaging a low number of epochs or in most cases
single recordings is largely sufficient to study LMEP amplitude.
This could be of interest in clinical routine, where time issues may
be important. Only one patient (PAT 5), showed a lower SNR
requiring 50 to 100 epochs to be gathered. Although breathing,
swallowing or cardiac pulse-related artifacts may affect the SNR
of LMEPs recordings, we demonstrated that by recording and
averaging 50 to 100 epochs, a reliable quantification of the LMEPs
can be provided in all cases. PAT 5 had been treated with VNS
for 8 years, and did not correspond to the patient with the
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FIGURE 8 | Comparison of LMEP recording with EH electrodes placed at 2,
4, and 6 cm laterally to the laryngeal prominence. The stimulation was
performed at 1.75 mA of current output (Xstim). The bright red lines represent
the averaged curve for each train. Muscular artifacts are more visible when
6 cm distance is used for the recording.
longest follow-up in our patient population (i.e., 14 years). We
did not find significant differences in amplitude measurements
of the LMEPs recorded from short and long-term follow-up
patients, i.e., implanted for less than 4 years vs. more than 4 years
(Englot et al., 2016).
Krahl et al. (2001) demonstrated that the effect of VNS on PTZ
induced seizures is still present after selective lesion of the vagal
C fibers with capsaicin, indicating that only low threshold A and
B fibers are possible candidates for the beneficial effects of VNS.
Many other studies further support the idea that low or medium
stimulus intensities are sufficient to achieve the therapeutic effects
(Zagon, 2000; Groves and Brown, 2005; Mollet et al., 2013).
Although the conduction velocity in our study cannot be directly
measured, due to a lack of information on the exact length of
the recurrent laryngeal nerve in each patient, an estimate can
be given. Taking into account the mean length of the recurrent
laryngeal nerve in humans (Prades et al., 2012) and the average
distance between placement of VNS electrode and branching of
the nerve (Krahl, 2012), and subtracting the transmission time
(1 ms) at the neuromuscular junction (Katz and Miledi, 1965)
from our mean latency findings, we can estimate the conduction
velocity to be 45.3 m/s (34.5–61.1 m/s). For this reason, we
assume that the activated fibers are Aα-fibers corresponding to
motor nerve fibers.
Until today, human data describing the effect of VNS on the
vocal cords are mostly results of laryngological studies (Shaffer
et al., 2005; Ardesch et al., 2007; Felisati et al., 2014; Al Omari
et al., 2017; Saibene et al., 2017) sometimes combined with
needle-EMG (Ardesch et al., 2007; Saibene et al., 2017). The main
goal of these studies was to better understand the nature of voice
disturbances in VNS-implanted patients. They pointed to the
frequent and most often partial vagus nerve damage, typically
temporary and recovering relatively quickly. However, the use
of invasive and costly laryngological techniques is not realistic
in the frame of a routine follow-up of epileptic patients treated
with VNS. In contrast, the surface recording of LMEP could
offer a solution. In our case, no test was performed earlier than
8 months after implantation, at a time where most nerve damages
would have recovered. The use of LMEPs to monitor the nerve
activation at an earlier, acute stage could be useful in guiding
proper stimulus titration.
Our study mainly focused on feasibility and methodology of
LMEPs recording, to be potentially used as biomarker of effective
vagus nerve activation. A correlation of LMEPs and the clinical
outcomes of the VNS therapy remained out of scope for this
study. However, we expect that some poor clinical responses
might be related to an impaired activation of the vagus nerve
due to local gliosis, demyelination, or axonal loss. Such problems
could result in absent LMEPs, reduced amplitudes, prolonged
latencies, prolonged response durations, abnormal shapes, or
distorted recruitment curves (Meulstee et al., 1997; Ridding
and Rothwell, 1997). In our study population, 3/11 patients
were considered responders to VNS (>50% seizure reduction).
Interestingly, 2/3 of these patients (PAT2 and PAT 9) presented
lower recruitment slope steepness and Boltzmann sigmoid curves
could be fitted. Clearly, the stimulus strength resolution available
to us was not sufficient to build a recruitment curve in all except
3 patients. As a strict minimum, we need at least one data point
below threshold, one above saturation and two on the slope.
Considering our results (Figure 6), a range of 0.15 to 1.5 mA
with at least a 10 step logarithmic increment scale should be
available in the future.
The three responders of our study population were responding
at 1 mA of current output, and no increase in LMEPs amplitude
was found in the following 1.25 mA train. Based on the
link between fiber diameter and activation threshold, it is our
expectation that the recruitment saturation of the clinically
pertinent sensory afferent fibers is related to the saturation
observed in motor fibers. The exact threshold ratio between
motor fibers and therapeutically pertinent afferent fibers has still
to be demonstrated. However, we found interesting that none of
the investigated responder patients received stimulation currents
stronger than the approximate 100% of the motor recruitment
saturation, while in several non-responders the output current
reaches the 200–250% of saturation.
Further studies are needed to elucidate the correlation
between LMEP recruitment curves and: (i) clinical response, (ii)
other markers of VNS-induced afferent activation (Hammond
et al., 1992; Usami et al., 2013). These comparisons could validate
the future use of LMEPs as a non-invasive read-out of therapeutic
vagal fiber activation. The applied stimulation frequency in our
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study was 20 Hz, which is largely above the refractory period of
the nerve (1 to 2 ms), making it possible to reliably study the
amplitude behavior across patients and across trains of different
current outputs. However, due to the reasons explained above,
a more precise current output ideally of 0.0625–0.125 mA, would
be necessary to quantify the recruitment in all patients.
Finally, hoping to limit any activation of the vagus nerve in
the caudal direction, some authors have focused on the anodal
block. However, the very existence of the LMEPs reported here
proves that anodal block may, at most, have a negligible effect.
Some solutions have been proposed to increase the anodal block
effect by using depolarizing and slowly rising pulses (Vuckovic
et al., 2008). This effect was mainly seen at very high charge
densities, which do not apply to the clinical parameters of VNS.
Moreover, Grimonprez et al. (2015) has shown in rats that
with clinically relevant parameters, changing the polarity of the
stimulation pulse did not affect the LMEP. Anodal block is
therefore not an issue here.
Larger prospective studies are necessary to explore the
full significance of this technique. Strength-duration curves
could not be fitted in this study, due to technical programing
constraints. However, considering the well-known relationship
between threshold and nerve fiber diameter, a constant but as yet
unknown ratio must exist between the threshold of the A-alpha
motor fibers activated here and the threshold to activate the
nerve fibers pertinent for the clinical effects of the VNS therapy
(McAllen et al., 2018). A direct estimation of the necessary
stimulus strength (current and duration) would then be possible
on the basis of the LMEP threshold.
CONCLUSION
In VNS-implanted patients, efferent activation of the recurrent
laryngeal nerve leads to a local muscular activation recordable
from the skin surface as LMEPs. The method only requires
a single horizontal recording dipole using surface electrodes
symmetrically placed on each side of the laryngeal prominence, at
half the distance between the midline and the medial edge of the
sternocleidomastoid muscle. LMEPs show very good reliability
and measurability over a long period of time. At most, single
trains of 50–100 stimuli at 20 Hz are sufficient to yield excellently
consistent measures. LMEPs directly measure the effectiveness
of electrical activation of motor efferent vagal nerve fibers. In
the future, they could be used in a clinical context as a possible
biomarker of effective nerve stimulation. Further studies are
needed to assess the relation between LMEP characteristics and
VNS clinical effect on seizures.
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